Apoptosis effects of Xrel3 c-Rel/nuclear factor-kappa B homolog in human cervical cancer cells

被引:8
|
作者
Shehata, M [1 ]
Shehata, M [1 ]
Shehata, F [1 ]
Pater, A [1 ]
机构
[1] Mem Univ Newfoundland, Fac Med, Div Basic Sci, St John, NF A1B 3V6, Canada
基金
加拿大健康研究院;
关键词
cervical cancer; HeLa cell; NF-kappa B; Xrel3; cisplatin; apoptosis; anti-apoptosis;
D O I
10.1016/j.cellbi.2004.12.014
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cervical cancer is considered a common yet preventable cause of death in women. In this report, we studied the role of the NF-kappa B gene family in HeLa human cervical cancer cells, using the Xre13 c-Rel homologue of Xenopus laevis. The expression of Xre13/c-Rel slowed cell growth 6-fold, consistent with an upregulated expression of the cell cycle inhibitor p21. The activated PARP apoptosis effector was significantly increased (P < 0.01), Based on cell viability assays Xre13 provided an anti-apoptotic effect in I PM cisplatin, and this was associated with significantly lower levels of the apoptotic proteins Bax and MDM-2 (P < 0.05). Furthermore, there was a 3-fold drop in the level of the tumor suppressor protein p53. In 5 mu M cisplatin, expression of HeLa Xre13 enhanced apoptosis by significantly increasing the expression of the apoptotic proteins Bax and MDM-2 (P < 0.05). However, the tumor suppressor protein p53 showed a significant decrease (P < 0.05) relative to the control. Thus, c-Rel/NF-kappa B may potentially be of clinical significance, especially in tumors exhibiting resistance to high-level chemotherapy. (c) 2005 International Federation for Cell Biology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:429 / 440
页数:12
相关论文
共 50 条
  • [1] Dual apoptotic effect of Xrel3 c-Rel/NF-κB homolog in human cervical cancer cells
    Shehata, M
    Shehata, M
    Shehata, F
    Pater, A
    CELL BIOLOGY INTERNATIONAL, 2004, 28 (12) : 895 - 904
  • [2] Rel/Nuclear factor-kappa B apoptosis pathways in human cervical cancer cells
    Shehata, Marlene F.
    CANCER CELL INTERNATIONAL, 2005, 5 (1)
  • [3] Rel/Nuclear factor-kappa B apoptosis pathways in human cervical cancer cells
    Marlene F Shehata
    Cancer Cell International, 5
  • [4] The role of Nuclear Factor-kappa B signaling in human cervical cancer
    Tilborghs, Sam
    Corthouts, Jerome
    Verhoeven, Yannick
    Arias, David
    Rolfo, Christian
    Trinh, Xuan Bich
    van Dam, Peter A.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 120 : 141 - 150
  • [5] Quercetin induces human colon cancer cells apoptosis by inhibiting the nuclear factor-kappa B Pathway
    Zhang, Xiang-An
    Zhang, Shuangxi
    Yin, Qing
    Zhang, Jing
    PHARMACOGNOSY MAGAZINE, 2015, 11 (42) : 404 - 409
  • [6] Nuclear factor-kappa B activation inhibits proliferation and promotes apoptosis of vascular smooth muscle cells
    Jiao, Lei
    Jiang, Ming
    Liu, Jun
    Wei, Lichao
    Wu, Min
    VASCULAR, 2018, 26 (06) : 634 - 640
  • [7] Coffee inhibits nuclear factor-kappa B in prostate cancer cells and xenografts
    Kolberg, Mark
    Pedersen, Sigrid
    Mitake, Maiko
    Holm, Kristine Lillebo
    Bohn, Siv Kjolsrud
    Blomhoff, Heidi Kiil
    Carlsen, Harald
    Blomhoff, Rune
    Paur, Ingvild
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2016, 27 : 153 - 163
  • [8] Nuclear factor-kappa B as potential therapeutic target in human colon cancer
    Plewka, Danuta
    Plewka, Andrzej
    Miskiewicz, Adam
    Morek, Michal
    Bogunia, Edyta
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (03) : 516 - 520
  • [9] Activation of nuclear factor-kappa B subunits c-Rel, p65 and p50 by plasma lipids and fatty acids across the menstrual cycle
    Faustmann, Gernot
    Tiran, Beate
    Trajanoski, Slave
    Obermayer-Pietsch, Barbara
    Gruber, Hans-Juergen
    Ribalta, Josep
    Roob, Johannes M.
    Winklhofer-Roob, Brigitte M.
    FREE RADICAL BIOLOGY AND MEDICINE, 2020, 160 : 488 - 500
  • [10] MAFIP is a tumor suppressor in cervical cancer that inhibits activation of the nuclear factor-kappa B pathway
    Li, Yang
    Yu, Yao
    Zhang, Yan
    Zhou, Yufei
    Li, Chao
    Zhu, Jianbing
    Yuan, Hanying
    Lu, Hong
    CANCER SCIENCE, 2011, 102 (11) : 2043 - 2050